TIDMEVC 
 
RNS Number : 1379O 
AIM 
02 March 2009 
 

+----------------------------------------------------------------------------+ 
|    ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN      | 
|    ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")     | 
+----------------------------------------------------------------------------+ 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| COMPANY NAME:                                                              | 
+----------------------------------------------------------------------------+ 
| Evolutec Group plc                                                         | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING        | 
| ADDRESS (INCLUDING POSTCODES) :                                            | 
+----------------------------------------------------------------------------+ 
| 3 More London Riverside, London, SE1 2AQ                                   | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| COUNTRY OF INCORPORATION:                                                  | 
+----------------------------------------------------------------------------+ 
| England & Wales                                                            | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE    | 
| 26:                                                                        | 
+----------------------------------------------------------------------------+ 
| www.evolutec.com                                                           | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF  | 
| AN INVESTING COMPANY, DETAILS OF ITS INVESTING STRATEGY). IF THE ADMISSION | 
| IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE | 
| STATED:                                                                    | 
+----------------------------------------------------------------------------+ 
| Evolutec Group plc ("Evolutec") is classed as an investment company under  | 
| the AIM Rules. The investment policy of Evolutes' has been to seek a       | 
| single investment, most probably of a UK or European business, in either   | 
| the technology, healthcare or service related sectors.                     | 
| The main country of operation is England.                                  | 
| The boards of Evolutec and Nanoco Tech Public Limited Company ("Nanoco")   | 
| have reached agreement on the terms of recommended share acquisition by    | 
| Evolutec of the entire issued and to be issued share capital of Nanoco to  | 
| be effected by means of a court approved scheme of arrangement.            | 
| Admission is sought as a result of a reverse take-over under Rule 14.      | 
| Nanoco is a leading nanotechnology company involved in the development and | 
| manufacture of fluorescent semi-conducting materials called quantum dots.  | 
| Quantum dots are a platform technology with uses in a wide range of        | 
| applications from life sciences through to optoeletronics dominated by     | 
| solid state lighting, photovoltaics and next generation displays.          | 
| Quantum dot based applications have the ability to potentially offer       | 
| significant benefits in performance and energy savings compared to those   | 
| materials currently used.                                                  | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO      | 
| TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares,   | 
| nominal value and issue price to which it seeks admission and the number   | 
| and type to be held as treasury shares):                                   | 
+----------------------------------------------------------------------------+ 
| 184,088,032 Ordinary Shares of 10p each                                    | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET   | 
| CAPITALISATION ON ADMISSION:                                               | 
+----------------------------------------------------------------------------+ 
| Anticipated market capitalisation upon admission - GBP38,658,487           | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:             | 
+----------------------------------------------------------------------------+ 
| 83.56%                                                                     | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM         | 
| SECURITIES (OR OTHER SECURITIES OF THE COMPANY) ARE OR WILL BE ADMITTED OR | 
| TRADED:                                                                    | 
+----------------------------------------------------------------------------+ 
| N/A                                                                        | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining  | 
| the first name by which each is known or including any other name by which | 
| each is known):                                                            | 
+----------------------------------------------------------------------------+ 
| Directors                                                                  | 
| Dr. David Philip Bloxham - Non-Executive Chairman                          | 
| Gordon James Hall - Non-Executive Director                                 | 
| Mark Barrie Hawtin - Non-Executive Director                                | 
| Graeme Manson Hart - Non-Executive Director                                | 
| Proposed Directors                                                         | 
| Dr. Peter John Rowley - Non-Executive Chairman                             | 
| Dr. Michael Albert Edelman - Chief Executive Officer                       | 
| Dr. Nigel Leroy Pickett - Chief Technical Officer                          | 
| Michael Anthony Bretherton - Chief Financial Officer                       | 
| Upon Admission the board of the Company will comprise of the Proposed      | 
| Directors and Gordon James Hall.                                           | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A         | 
| PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION         | 
| (underlining the first name by which each is known or including any other  | 
| name by which each is known):                                              | 
+----------------------------------------------------------------------------+ 
| Before Admission                                                           | 
| Gartmore Investment Management Limited - 25.99%                            | 
| Bluehone Investors LLP - 12.16%                                            | 
| Fortis Bank - 11.06%                                                       | 
| GAM International - 10.87%                                                 | 
| Close Asset Management - 5.07%                                             | 
| Charles Stanley - 4.24%                                                    | 
| After Admission                                                            | 
| ORA Guernsey - 36.34%                                                      | 
| Gartmore - 16.10%                                                          | 
| Mitsubishi UFJ - 6.45%                                                     | 
| Nigel Pickett - 5.67%                                                      | 
| Paul O'Brien - 5.39%                                                       | 
| Michael Edelman - 5.03%                                                    | 
| Manchester Tech Fund - 3.73%                                               | 
| Nora Powell - 3.26%                                                        | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2,        | 
| PARAGRAPH (H) OF THE AIM RULES:                                            | 
+----------------------------------------------------------------------------+ 
| None                                                                       | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| *  ANTICIPATED ACCOUNTING REFERENCE DATE *                                 | 
| DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS | 
| BEEN PREPARED (this may be represented by unaudited interim financial      | 
| information)*                                                              | 
| DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM     | 
| RULES 18 AND 19:                                                           | 
+----------------------------------------------------------------------------+ 
| *  31 December*                                                            | 
| Years ended 31 December 2006, 2007 and 2008.*                              | 
| 31 September 2009 (Interims) 31 June 2010 (Annual Accounts) 31 September   | 
| 2010 (Interims)                                                            | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| EXPECTED ADMISSION DATE:                                                   | 
+----------------------------------------------------------------------------+ 
| 30 April 2009                                                              | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| NAME AND ADDRESS OF NOMINATED ADVISER:                                     | 
+----------------------------------------------------------------------------+ 
| Zeus Capital Limited                                                       | 
| 3 Ralli Courts                                                             | 
| West Riverside                                                             | 
| Manchester                                                                 | 
| M3 5FT                                                                     | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| NAME AND ADDRESS OF BROKER:                                                | 
+----------------------------------------------------------------------------+ 
| Zeus Capital Limited                                                       | 
| 3 Ralli Courts                                                             | 
| West Riverside                                                             | 
| Manchester                                                                 | 
| M3 5FT                                                                     | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR  | 
| INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A    | 
| STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE  | 
| ADMISSION OF ITS SECURITIES:                                               | 
+----------------------------------------------------------------------------+ 
| The Admission document will be available from the following address and    | 
| will contain full details about the applicant and the admission of its     | 
| securities;                                                                | 
| Zeus Capital Limited                                                       | 
| 3 Ralli Courts                                                             | 
| West Riverside                                                             | 
| Manchester                                                                 | 
| M3 5FT                                                                     | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| DATE OF NOTIFICATION:                                                      | 
+----------------------------------------------------------------------------+ 
| 2 March 2009                                                               | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
| NEW/ UPDATE:                                                               | 
+----------------------------------------------------------------------------+ 
| New                                                                        | 
|                                                                            | 
+----------------------------------------------------------------------------+ 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 PAAILFEFVRIFIIA 
 

Evolutec (LSE:EVC)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024 Haga Click aquí para más Gráficas Evolutec.
Evolutec (LSE:EVC)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024 Haga Click aquí para más Gráficas Evolutec.